Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds
about
Biological properties of solid free form designed ceramic scaffolds with BMP-2: in vitro and in vivo evaluationRecent advances in nano scaffolds for bone repairBone Physiology, Biomaterial and the Effect of Mechanical/Physical Microenvironment on MSC Osteogenesis: A Tribute to Shu Chien's 80th BirthdayTowards excimer-laser-based stereolithography: a rapid process to fabricate rigid biodegradable photopolymer scaffolds.Solid Free-form Fabrication Technology and Its Application to Bone Tissue Engineering.Surface modification of PdlLGA microspheres with gelatine methacrylate: Evaluation of adsorption, entrapment, and oxygen plasma treatment approaches.Novel scaffolds fabricated using oleuropein for bone tissue engineering.Three-dimensional bioprinting in tissue engineering and regenerative medicine.Spatial regulation of controlled bioactive factor delivery for bone tissue engineering.Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite--an animal model.In vitro degradability, bioactivity and primary cell responses to bone cements containing mesoporous magnesium-calcium silicate and calcium sulfate for bone regeneration.A review on powder-based additive manufacturing for tissue engineering: selective laser sintering and inkjet 3D printingFunctionalized d-form self-assembling peptide hydrogels for bone regeneration.An in vitro study of composites of poly(L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis.Brain tissue interaction with three-dimensional, honeycomb polycaprolactone-based scaffolds designed for cranial reconstruction following traumatic brain injury.Calcium phosphate deposition rate, structure and osteoconductivity on electrospun poly(l-lactic acid) matrix using electrodeposition or simulated body fluid incubation.Biomimetic coatings for bone tissue engineering of critical-sized defectsMaterials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspectsThree-dimensional glass-derived scaffolds for bone tissue engineering: current trends and forecasts for the future.Drug delivery in soft tissue engineering.The use of micro- and nanospheres as functional components for bone tissue regeneration.Microfabricated particulate drug-delivery systems.Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments.Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review.Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants.Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application.Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering.The role of osteoclasts in bone tissue engineering.Drug delivery using composite scaffolds in the context of bone tissue engineering.Polymeric scaffolds as stem cell carriers in bone repair.Toughening and functionalization of bioactive ceramic and glass bone scaffolds by biopolymer coatings and infiltration: a review of the last 5 years.Sustained delivery of biomolecules from gelatin carriers for applications in bone regeneration.Review and the state of the art: Sol-gel and melt quenched bioactive glasses for tissue engineering.Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.Bone-tissue engineering: complex tunable structural and biological responses to injury, drug delivery, and cell-based therapies.Pamidronate-Conjugated Biodegradable Branched Copolyester Carriers: Synthesis and Characterization.Mechanical properties and drug release behavior of PCL/zein coated 45S5 bioactive glass scaffolds for bone tissue engineering application.Anti-biofilm properties of bioactive glasses embedding organic active compounds.Correlation of the intracellular reactive oxygen species levels with textural properties of functionalized mesostructured silica.Evaluation of antibacterial and cytotoxic effects of nano-sized bioactive glass/collagen composites releasing tetracycline hydrochloride.
P2860
Q27305463-1177290B-0307-41E1-99FF-E8A7BF81410BQ28077442-9F70FBAD-58EE-49FA-846A-1A4EB80F28C5Q28652480-ACC18E6A-80B2-4B54-9819-7123EE70B60CQ30526445-7123CEF6-968F-4B5D-BE19-B21BB046173EQ33614871-CDF4D2E4-A239-40FC-85B0-A39657D9DBD1Q33656519-4EFC6D02-6D77-401E-85CC-E7F5CEEB79CFQ33738235-6BDB5202-F7CE-45E1-B6C7-ED509BA39869Q34497979-CAF84919-56CA-4755-B07B-9C1C7D13EC15Q35598154-A4259285-A499-427D-B81D-D5DB1F145111Q35885329-CB7BF79A-B243-4016-B285-E9A7B488355DQ36187879-2F38D6E2-0DD6-409C-AEF7-BD705A478BC9Q36201977-AF3DE988-22FA-4F36-B927-D41784D38E72Q36802790-429B1DB9-960F-4DB9-B6CB-9AAF6DB57501Q37111778-4DD0F649-AA27-498C-B9CB-0A6A24EEE099Q37253307-19236738-C0DC-487B-90C9-931A82464C07Q37341589-CADEB43E-B049-4E95-A0CE-1B2527239E39Q37756361-E6DDC9AB-1876-4396-8632-25020F4B06CAQ37801284-DDB1EFA9-0CAE-45B2-BC5E-3E691B9DEB3EQ37861641-9B482061-2FA1-4D51-9C17-A736CE002301Q37890406-64A75526-B800-4621-85C3-E46DA0EB5A42Q37909452-7319297C-C218-4E20-998F-C26864A20AE0Q37955127-DE4793D3-F271-4A86-BD9D-ABEF04C38FB2Q37967128-36045CF5-A5F0-4F0E-8071-030DCF0B3371Q37987823-DA6D787D-1D47-4EB6-81C7-BB99B93A880FQ37996117-56A74D5E-7E72-4331-B348-B2C91965D798Q38112427-8A3E4048-CDCE-4347-BD4D-8A13AD4C993AQ38115348-D8B1E241-2908-42D6-B6F9-5AD825D9B510Q38183343-DF5A1117-40ED-4761-9656-3B2C81AF027EQ38189789-92A1906A-467F-4F65-A029-28597A05968AQ38199462-52CEC51F-011F-4A60-BF54-EAA7F33618BDQ38261522-287669A9-FE5E-48E5-AAE5-3CA009365943Q38261963-E0E2BCEF-79C4-403A-AF7B-8147427D4EA4Q38523506-6E657D21-A472-47E6-AA86-637B0F1FA3E5Q38647414-30A309AC-B972-4F66-87EA-F43BCE3B397EQ38664383-A067613E-C9D2-4669-9C52-0EDF9764C1B6Q38695991-9AC01CC8-9372-4966-93F4-97B4DD3558BDQ38854607-A25C8294-9264-4353-9B43-52E4F0F1A20FQ38983064-DCE71300-E12C-41CD-ACF7-8C3AF726F98EQ39010664-2741E0DC-2DBE-4D9D-BEE1-BB0BA02109D5Q39023866-8DE7B112-DD1F-45E6-A705-4B772AEDC88F
P2860
Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bone tissue engineering therap ...... in three-dimensional scaffolds
@ast
Bone tissue engineering therap ...... in three-dimensional scaffolds
@en
type
label
Bone tissue engineering therap ...... in three-dimensional scaffolds
@ast
Bone tissue engineering therap ...... in three-dimensional scaffolds
@en
prefLabel
Bone tissue engineering therap ...... in three-dimensional scaffolds
@ast
Bone tissue engineering therap ...... in three-dimensional scaffolds
@en
P2860
P356
P1476
Bone tissue engineering therap ...... in three-dimensional scaffolds
@en
P2093
Viviana Mouriño
P2860
P304
P356
10.1098/RSIF.2009.0379
P577
2009-10-28T00:00:00Z